High-content drug screening with engineered musculoskeletal tissues

Area of Science:

• Biomedical Engineering
• Translational Research
• Drug Discovery

Background:

• Tissue engineering enables in vitro drug screening based on functional tissue assessment.
• High-content screening (HCS) evaluates cumulative compound effects on multiple pathways, unlike high-throughput screening.
• Engineered tissues can predict in vivo drug activity better than traditional methods.

Purpose of the Study:

• To develop and utilize high-content screening (HCS) with engineered musculoskeletal tissues for drug discovery.
• To establish rapid, cost-effective methods for assessing compound effects on tissue function.
• To reduce reliance on animal models in preclinical drug testing.

Main Methods:

• Development of miniature engineered musculoskeletal organs (bone, tendon, cartilage, skeletal muscle).
• Implementation of automated functional testing for mechanical and contractile properties.
• Application of HCS to evaluate compound impacts on engineered tissue function.

Main Results:

• Engineered tissues allow for complex assessment of drug effects on multiple biological pathways.
• HCS with engineered tissues provides a bridge between high-throughput screening and in vivo studies.
• Potential for identifying compounds that enhance musculoskeletal tissue repair and regeneration.

Conclusions:

• HCS using engineered musculoskeletal tissues is a promising approach for in vitro drug screening.
• This technology can improve prediction of in vivo drug efficacy and reduce animal usage.
• Clinical applications include developing treatments for musculoskeletal disorders.